Log in to save to my catalogue

Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy : Na...

Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy : Na...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3198603

Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy : National Cancer Institute, Mexico City, Mexico

About this item

Full title

Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy : National Cancer Institute, Mexico City, Mexico

Publisher

Cairo, Egypt: Hindawi Puplishing Corporation

Journal title

ISRN oncology, 2011-01, Vol.2011 (2011), p.1-6

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Puplishing Corporation

More information

Scope and Contents

Contents

Peritoneal carcinomatosis (PC) is generally considered a lethal disease, with a poor prognosis. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a new approach for peritoneal surface disease. This study investigated the early experience with this combined modality treatment at a single institute. Fro...

Alternative Titles

Full title

Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy : National Cancer Institute, Mexico City, Mexico

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3198603

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3198603

Other Identifiers

ISSN

2090-5661

E-ISSN

2090-567X

DOI

10.5402/2011/526384

How to access this item